Patents by Inventor Chris GALLIANO

Chris GALLIANO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PROTEASOME INHIBITORS IN THE TREATMENT OF CORONAVIRUS INFECTIONS
    Publication number: 20240115588
    Abstract: Oral formulations comprising one or more proteasome inhibitors for use as a treatment of coronavirus infection in a subject. Also disclosed are the use of such for the treatment or prevention of SARS-CoV-2 infection in humans.
    Type: Application
    Filed: February 1, 2022
    Publication date: April 11, 2024
    Applicants: Board of Supervisors of Louisiana state University and Agricultural and Mechanical College, Skymount Medical US lnc.
    Inventors: Adam Bess, Frej Knut Gosta BERGLIND, Supratik MUKHOPADHYAY, Kishor M. WASAN, Chris GALLIANO, Michal BRYLINSKI, Stephania CORMIER, Allan ADER, Nicholas GRIGGS, Janet GOULD, Tiffany CHO, Julia ABRAMOV, Peter HNIK
  • METHODS OF TREATING CORONAVIRUS DISEASE AND COMPOUNDS FOR SAME
    Publication number: 20230398114
    Abstract: A tyrosine kinase inhibitor for use in the treatment of COVID-19 and/or its associated symptoms. Also disclosed is a method of treating an individual infected with a coronavirus, wherein said method comprises the steps of: providing a tyrosine kinase inhibitor; and administering said tyrosine kinase inhibitor to said individual in a dosage amount sufficient to prevent/stabilize/reduce the risks and/or symptoms associated with a coronavirus infection.
    Type: Application
    Filed: November 2, 2021
    Publication date: December 14, 2023
    Inventors: Kishor M. WASAN, Chris GALLIANO, Supratik MUKHOPADHYAY, Adam BESS, Frej Knut Gosta BERGLIND, Stephania CORMIER, Allan ADER, Nicholas GRIGGS, Janet GOULD, Tiffany CHO, Julia ABRAMOV, Peter HNIK, Michal BRYLINSKI